Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 736Generated: October 27, 2026

N-(5-amino-2-cyclopropylphenyl)acetamide → N-[5-[[3-cyano-7-(oxetan-3-ylamino)pyrazolo[1,5-a]pyrimidin-5-yl]amino]-2-cyclopropylphenyl]acetamide

https://huagongshe.com/reaction/736

Reaction equation

Participants

RoleNameHCIDCharge
ReactantN-(5-amino-2-cyclopropylphenyl)acetamideHCID 89098640—
ReactantHCID 178418222HCID 178418222—
ReagentCesium carbonateHCID 10796—
CatalystBis(dibenzylideneacetone)palladiumHCID 9811564—
CatalystDi-tert-butyl(2',4',6'-tris(propan-2-yl)-(1,1'-biphenyl)-2-yl)phosphaneHCID 11618717—
SolventDimethylacetamideHCID 31374—
ProductN-[5-[[3-cyano-7-(oxetan-3-ylamino)pyrazolo[1,5-a]pyrimidin-5-yl]amino]-2-cyclopropylphenyl]acetamideHCID 721642896.96%

Reaction Conditions

Temperature150 °C

Reaction Steps

A 10 mL microwave reactor vial was charged with 5-chloro-7-(oxetan-3-ylamino)pyrazolo[1,5-a]pyrimidine-3-carbonitrile (80 mg, 0.32 mmol), N-(5-amino-2-cyclopropylphenyl)acetamide (67.1 mg, 0.35 mmol), Cs2CO3 (313 mg, 0.96 mmol), Pd2(dba)3 (14.67 mg, 0.02 mmol) and 2-Di-t- butylphosphino-2',4',6'-tri-i-propyl-1,1'-biphenyl (13.61 mg, 0.03 mmol). The suspended in DMA (.5 mL), added via syringe. The resulting brown suspension was stirred under nitrogen, then microwave vial capped and heated at 150 °C under microwave irradiation for 20 min. LCMS indicated formation of product. The cooled reaction mixture was put through vacuum filtration and concentrated in rotovap. The crude material was purified by ISCO using MeOH and EtOAc (1:10). The solid was suspended in water, stirred for 12 h at rt, repurified with EtOAc, collected and dried to afford a light brown powder (9 mg, 6%) at 93% purity. LCMS, HPLC, and HNMR consistent with desired product- see attached.

Provenance & Evidence

Source dataset750 AstraZeneca ELN dataset
ORD IDord-a242bdcea6fd4820b97f40b83c063cc9
Source note750 AstraZeneca ELN dataset